Tisha San Miguel

3.9k total citations
13 papers, 219 citations indexed

About

Tisha San Miguel is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Tisha San Miguel has authored 13 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Tisha San Miguel's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Tisha San Miguel is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Tisha San Miguel collaborates with scholars based in United States. Tisha San Miguel's co-authors include John D. McCarter, Victor J. Cee, Tara Arvedson, Iain D. G. Campuzano, Leeanne Zalameda, Mark H. Norman, Raju Subramanian, Nancy R. Zhang, Ling Wang and Kristin L. Andrews and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Tisha San Miguel

13 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tisha San Miguel United States	9	154	92	26	23	22	13	219
Kelly M. George United States	7	102 0.7×	157 1.7×	47 1.8×	28 1.2×	37 1.7×	12	325
Alan T. Henley United Kingdom	7	158 1.0×	97 1.1×	38 1.5×	14 0.6×	29 1.3×	12	267
Mickael Mogemark Sweden	10	214 1.4×	136 1.5×	31 1.2×	11 0.5×	19 0.9×	16	262
Lara Ward United Kingdom	8	172 1.1×	72 0.8×	37 1.4×	6 0.3×	18 0.8×	14	263
Adriana Stroba Germany	6	342 2.2×	85 0.9×	34 1.3×	7 0.3×	52 2.4×	6	407
Daniele Volpi Italy	8	119 0.8×	70 0.8×	37 1.4×	5 0.2×	12 0.5×	13	254
D.M. Smith United States	8	200 1.3×	97 1.1×	34 1.3×	37 1.6×	10 0.5×	10	381
Mark T. Kershaw United States	8	113 0.7×	174 1.9×	21 0.8×	8 0.3×	17 0.8×	10	318
David Koditek United States	7	167 1.1×	96 1.0×	29 1.1×	47 2.0×	8 0.4×	8	254
Mark A. Bobko United States	11	194 1.3×	197 2.1×	45 1.7×	4 0.2×	26 1.2×	16	344

Countries citing papers authored by Tisha San Miguel

Since Specialization

Citations

This map shows the geographic impact of Tisha San Miguel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tisha San Miguel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tisha San Miguel more than expected).

Fields of papers citing papers by Tisha San Miguel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tisha San Miguel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tisha San Miguel. The network helps show where Tisha San Miguel may publish in the future.

Co-authorship network of co-authors of Tisha San Miguel

This figure shows the co-authorship network connecting the top 25 collaborators of Tisha San Miguel. A scholar is included among the top collaborators of Tisha San Miguel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tisha San Miguel. Tisha San Miguel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Saiki, Anne Y., Kevin Gaida, Karen Rex, et al.. (2019). Abstract 4484: Discovery and in vitro characterization of AMG 510–a potent and selective covalent small-molecule inhibitor of KRAS^G12C. 4484–4484. 1 indexed citations

2.

Saiki, Anne Y., Kevin Gaida, Karen Rex, et al.. (2019). Abstract 4484: Discovery and in vitro characterization of AMG 510–a potent and selective covalent small-molecule inhibitor of KRASG12C. Cancer Research. 79(13_Supplement). 4484–4484. 13 indexed citations

3.

Stec, Markian M., Kristin L. Andrews, Yunxin Bo, et al.. (2015). The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(19). 4136–4142. 18 indexed citations

4.

Bui, Minna, Xiaolin Hao, Youngsook Shin, et al.. (2015). Synthesis and SAR study of potent and selective PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(5). 1104–1109. 18 indexed citations

5.

Campuzano, Iain D. G., et al.. (2015). High-Throughput Mass Spectrometric Analysis of Covalent Protein-Inhibitor Adducts for the Discovery of Irreversible Inhibitors: A Complete Workflow. SLAS DISCOVERY. 21(2). 136–144. 46 indexed citations

6.

Lanman, Brian A., Anthony B. Reed, Victor J. Cee, et al.. (2014). Phosphoinositide-3-kinase inhibitors: Evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511. Bioorganic & Medicinal Chemistry Letters. 24(24). 5630–5634. 3 indexed citations

7.

Harrington, Paul E., Matthew P. Bourbeau, Christopher Fotsch, et al.. (2013). The optimization of aminooxadiazoles as orally active inhibitors of Cdc7. Bioorganic & Medicinal Chemistry Letters. 23(23). 6396–6400. 14 indexed citations

8.

Bryan, Marian C., James R. Falsey, Mike Frohn, et al.. (2013). N-substituted azaindoles as potent inhibitors of Cdc7 kinase. Bioorganic & Medicinal Chemistry Letters. 23(7). 2056–2060. 28 indexed citations

9.

Wurz, Ryan P., Longbin Liu, Kevin Yang, et al.. (2012). Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold. Bioorganic & Medicinal Chemistry Letters. 22(17). 5714–5720. 23 indexed citations

10.

Zhang, Yihong, Robert J. Kurzeja, James Zondlo, et al.. (2011). Abstract 253: Identification of STK33 kinase inhibitors for the validation of a synthetic lethal relationship between STK33 and mutant KRAS. Cancer Research. 71(8_Supplement). 253–253. 1 indexed citations

11.

Stec, Markian M., Kristin L. Andrews, Shon K. Booker, et al.. (2011). Structure–Activity Relationships of Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Investigations of Various 6,5-Heterocycles to Improve Metabolic Stability. Journal of Medicinal Chemistry. 54(14). 5174–5184. 34 indexed citations

12.

Yu, Violeta, Yanyan Tudor, Clarence Hale, et al.. (2007). High Capacity Homogeneous Non-Radioactive Cortisol Detection Assays for Human 11 β -Hydroxysteroid Dehydrogenase Type 1. Assay and Drug Development Technologies. 5(1). 105–116. 1 indexed citations

13.

Kha, Hue T., Wen Zhou, Tisha San Miguel, et al.. (2004). A telomerase enzymatic assay that does not use polymerase chain reaction, radioactivity, or electrophoresis. Analytical Biochemistry. 331(2). 230–234. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact